In 2026, the pharmaceutical industry fully implements the new GMP and pharmacopoeia standards, upgrading towards asepsis, greenization and intelligence. Pharmaceutical grade carbon dioxide (CO₂) has become a core process gas for pharmaceutical production, running through the entire workflow of API preparation, biological fermentation, aseptic filling and preparation preservation.

In 2026, the pharmaceutical industry fully implements the new GMP and pharmacopoeia standards, upgrading towards asepsis, greenization and intelligence. Pharmaceutical grade carbon dioxide (CO₂) has become a core process gas for pharmaceutical production, running through the entire workflow of API preparation, biological fermentation, aseptic filling and preparation preservation. It effectively solves the industry pain points in traditional processes, such as solvent residues, component oxidation, insufficient aseptic control and difficulty in compliance inspection. From chemical synthesis, biopharmaceutical preparation to high-end injection production, a compliant and high-purity CO₂ application solution is the key support for pharmaceutical enterprises to pass authoritative certifications, ensure drug safety and achieve lean production.

Core Application Scenarios

Supercritical Extraction and Purification: As a green solvent, pharmaceutical grade CO₂ replaces organic solvents to extract active ingredients from natural medicines and APIs, with no residues or pollution. The extraction purity is increased by 30%, perfectly meeting the requirements of green pharmaceutical production in 2026.

Fermentation Process Regulation: Precisely adjust the pH value in biopharmaceutical fermentation, maintain stable metabolism of strains, improve fermentation efficiency, shorten production cycle, and ensure the consistency of biopharmaceutical batches.

Aseptic Process Protection: High-purity CO₂ filtered by 0.22μm sterilizing filter is used in aseptic filling and lyophilization processes, isolating oxygen to prevent drug oxidation and degradation, and creating a compliant and aseptic environment for injections and biological preparations.

Preparation Packaging and Preservation: As an inert protective gas, it is filled into drug packaging to delay component deterioration, extend drug shelf life, and improve the stability and shelf life of preparations.

Core Values

Compliance and Certification: Meets international pharmacopoeia standards such as ChP, USP and EP, with low impurities, sterility and no particles, helping pharmaceutical enterprises pass GMP unannounced inspections smoothly.

Green Quality Improvement: No organic solvent residues, improving drug purity and safety, and increasing the yield of high-quality products by more than 20%.

Efficiency and Cost Reduction: The intelligent dosing system accurately controls the dosage, improves gas utilization rate by 30%, and reduces production and compliance costs.

Stable Production: The closed and clean gas supply system eliminates pollution risks and ensures the stable operation of continuous and intelligent production lines.

2026 Selection Key Points

Choose pharmaceutical grade carbon dioxide with purity ≥99.99% and strict control of toxic impurities; match with 316L stainless steel clean pipelines, which are free of dead corners and easy to sterilize; select service providers with GMP certification service capabilities to provide full-process verification and quality traceability.

The core of carbon dioxide application in pharmaceutical production in 2026 lies in high purity, sterility, compliance and stable supply. Choosing the right gas solution is the core key for pharmaceutical enterprises to adhere to the quality bottom line and enhance market competitiveness. For customized pharmaceutical grade CO₂ solutions or to inquire about product specifications and quotes, please feel free to contact us.